A phase 1 study of combined guadecitabine and cisplatin in platinum refractory germ cell cancer

202036 citationsJournal Articlegold Open Access

Authors

The combination of guadecitabine and cisplatin was tolerable and demonstrated activity in patients with platinum refractory germ cell cancer.

Good health and well-being

Published in: Cancer Medicine

Volume 10, Issue 1, pp. 156-163

Field-Weighted Citation Impact: 4.70